From: Clinical characteristics and risk factors associated with bone erosion in patients with tophi
Ā | Ī² | OR (95% CI) | P value |
---|---|---|---|
N (male) | -1.342 | 0.261(0.063ā1.077) | 0.063 |
Age | 0.031 | 1.031(1.010ā1.053) | 0.004 |
BMI | -0.067 | 0.936(0.867ā1.009) | 0.085 |
Gout duration | 0.081 | 1.085(1.028ā1.145) | 0.003 |
Tophi duration | 0.156 | 1.169(1.062ā1.288) | 0.002 |
GFR | -0.013 | 0.987(0.975ā0.999) | 0.035 |
Hypertension | -0.006 | 0.994(0.557ā1.774) | 0.983 |
Diabetes | -0.566 | 0.568(0.237ā1.358) | 0.203 |
Smoking history | 0.535 | 1.708(0.962ā3.034) | 0.068 |
Drinking history | 0.853 | 2.346(1.236ā4.450) | 0.009 |
Ulceration | 1.092 | 2.979(1.353ā6.562) | 0.007 |
WBC count | 0.080 | 1.084(0.994ā1.182) | 0.069 |
PLT count | 0.001 | 1.001(0.999ā1.004) | 0.323 |
HGB | -0.005 | 0.995(0.982ā1.008) | 0.431 |
ALT | -0.003 | 0.997(0.986ā1.009) | 0.631 |
sUA | <0.001 | 1.000(0.998ā1.003) | 0.794 |
sCr | 0.013 | 1.013(1.004ā1.022) | 0.005 |
CRP | -0.001 | 0.999(0.992ā1.006) | 0.752 |
ESR | <0.001 | 1.000(0.992ā1.008) | 0.965 |